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Objectives
It is well known that a sequentially monitored clinical
trial that stops early for benefit has a crude treatment
difference that overestimates the true treatment effect.
This has led to extended debate in the literature, with
some researchers arguing that early stopping is an
important source of bias in meta-analyses of clinical
trials. We therefore investigated the implications of
excluding studies that stopped early, so-called truncated
studies, from estimation of treatment effects.
Methods
The effect of excluding truncated studies was investi-
gated by examining the statistical properties of sequen-
tially monitored studies conditional on reaching the
planned final analysis. Using theory and simulation we
studied clinical trials with standard sequential rules for
stopping early due to benefit. As well as estimation bias,
we studied information bias measured as the difference
between standard measures of the statistical informa-
tion, such as sample size, and the actual information
based on the conditional sampling distribution.
Results
We found exclusion of truncated studies leads to both
estimation bias and information bias. Treatment differ-
ences are underestimated and information is overesti-
mated. Most importantly, the magnitude of information
bias is an increasing function of the magnitude of esti-
mation bias. This has important implications for meta-
analyses that typically weight by sample size. In particu-
lar, it means that studies with the most biased treatment
effect are the most overweighted studies in a meta-ana-
lysis. The magnitudes of both estimation and informa-
tion biases can be practically significant. When all
studies were included in meta-analyses, both truncated
and non-truncated, the estimation of treatment effects
was unbiased.
Conclusions
Crude methods of analysis for sequentially monitored
studies can lead to underestimation bias if truncated
studies are excluded from estimation of treatment
effects. Furthermore, information bias resulting from
this exclusion leads to a double whammy effect, in
which the most biased studies are the most over-
weighted studies in a meta-analysis. Since exclusion of
truncated studies is problematic, we advocate wider
reporting of adjusted estimates of treatment effects that
take account of any interim monitoring, and recom-
mend that all studies, both truncated and non-truncated,
are included in meta-analyses.
Published: 13 December 2011
doi:10.1186/1745-6215-12-S1-A50
Cite this article as: Schou and Marschner: Biases in clinical trials with
sequential monitoring. Trials 2011 12(Suppl 1):A50.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submitDepartment of Statistics, Macquarie University, Sydney, NSW 2109, Australia
Schou and Marschner Trials 2011, 12(Suppl 1):A50
http://www.trialsjournal.com/content/12/S1/A50 TRIALS
© 2011 Schou and Marschner; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
